Related Experiment Video

Updated: May 20, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

[Metabolic syndrome in children]

E A Potapova

    Eksperimental'Naia I Klinicheskaia Gastroenterologiia = Experimental & Clinical Gastroenterology
    |July 20, 2012
    PubMed

    Insights

    Metabolic syndrome (MS) in children presents diagnostic challenges due to varied symptoms often masked by other conditions. This study highlights a clinical case to improve pediatric MS diagnosis tactics.

    Area of Science:

    • Pediatrics
    • Endocrinology
    • Metabolic Disorders

    Background:

    • Metabolic syndrome (MS) is a significant pediatric concern characterized by diverse clinical presentations.
    • Diagnosis is complicated by a lack of uniform criteria and the frequent masking of symptoms by associated diseases.
    • Core components include dyslipidemia, insulin resistance, and compensatory hyperinsulinemia.

    Observation:

    • Pediatric MS manifestations are often subtle and can be mistaken for other conditions.
    • Clinical symptoms may be hidden, delaying or preventing accurate MS diagnosis in children.
    • This case illustrates the complexities encountered in identifying MS in a pediatric patient.

    Findings:

    • The study presents a clinical example detailing the difficulties in diagnosing MS in children.
    • It emphasizes the need for heightened clinical suspicion and targeted diagnostic approaches.
    • The case underscores the importance of recognizing preclinical and masked signs of MS.

    Implications:

    • Optimizing diagnostic tactics for pediatric MS is crucial for timely intervention.
    • Improved diagnostic strategies can lead to earlier management of metabolic disorders in children.
    • Addressing MS in pediatrics is vital for preventing long-term cardiovascular and metabolic complications.

    More Related Videos

    Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

    Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

    Published on: July 29, 2020

    An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment10:31

    An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment

    Published on: April 20, 2018

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Type II Diabetes I: Introduction01:26

    Type II Diabetes I: Introduction

    Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
    Obesity01:24

    Obesity

    The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
    Overview of Carbohydrate Metabolism01:19

    Overview of Carbohydrate Metabolism

    Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
    Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
    Type II Diabetes II: Pathophysiology01:24

    Type II Diabetes II: Pathophysiology

    PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.